FDA Panel Gives Blessing to New Weight-Loss Drug
THURSDAY, May 10 (HealthDay News) — An advisory panel to the U.S. Food and Drug Administration on Thursday recommended approval of the weight-loss medication lorcaserin, even though concerns remain about cardiovascular side effects.